Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Age-appropriate use of human papillomavirus vaccines in the U.S.

Castle PE, Fetterman B, Akhtar I, Husain M, Gold MA, Guido R, Glass AG, Kinney W.

Gynecol Oncol. 2009 Aug;114(2):365-9. doi: 10.1016/j.ygyno.2009.04.035. Epub 2009 May 22. Review.

2.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
3.

Human papillomavirus vaccines versus cervical cancer screening.

Stanley M.

Clin Oncol (R Coll Radiol). 2008 Aug;20(6):388-94. doi: 10.1016/j.clon.2008.04.006. Epub 2008 Jun 5. Review.

PMID:
18538554
4.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
7.

HPV prophylactic vaccination: The first years and what to expect from now.

Villa LL.

Cancer Lett. 2011 Jun 28;305(2):106-12. doi: 10.1016/j.canlet.2010.12.002. Epub 2010 Dec 28. Review.

PMID:
21190794
8.

HPV Vaccines: today and in the Future.

Moscicki AB.

J Adolesc Health. 2008 Oct;43(4 Suppl):S26-40. doi: 10.1016/j.jadohealth.2008.07.010. Review.

9.
10.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

11.

[Diseases caused by human papilloma viruses].

Zollner U, Schwarz TF.

Dtsch Med Wochenschr. 2011 May;136(20):1067-72. doi: 10.1055/s-0031-1275845. Epub 2011 May 10. Review. German.

PMID:
21560109
12.

The impact of human papillomavirus vaccination on cervical cancer prevention efforts.

Massad LS, Einstein M, Myers E, Wheeler CM, Wentzensen N, Solomon D.

Gynecol Oncol. 2009 Aug;114(2):360-4. doi: 10.1016/j.ygyno.2009.04.005. Epub 2009 May 1. Review.

13.

Evaluation of the interim analysis from the PATRICIA study group: efficacy of a vaccine against HPV 16 and 18.

Frederick PJ, Huh WK; PATRICIA Study Group.

Expert Rev Anticancer Ther. 2008 May;8(5):701-5. doi: 10.1586/14737140.8.5.701. Review. Erratum in: Expert Rev Anticancer Ther. 2008 Jun;8(6):1014.

PMID:
18471043
14.

The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.

Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.

Eur J Gynaecol Oncol. 2005;26(2):129-42. Review.

PMID:
15857016
15.

Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M.

Cancer. 2008 Oct 1;113(7 Suppl):1980-93. doi: 10.1002/cncr.23704. Review.

16.

HPV and cervical cancer: screening or vaccination?

Bosch FX, Castellsagué X, de Sanjosé S.

Br J Cancer. 2008 Jan 15;98(1):15-21. doi: 10.1038/sj.bjc.6604146. Epub 2008 Jan 8. Review.

17.

Cervical cancer vaccine development.

Frazer IH.

Sex Health. 2010 Sep;7(3):230-4. doi: 10.1071/SH09132. Review.

PMID:
20719210
18.

Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?

Saleem A, Tristram A, Fiander A, Hibbitts S.

Minerva Med. 2009 Dec;100(6):503-23. Review.

PMID:
20010484
19.

[Human papillomavirus prophylactic vaccines: stakes and perspectives].

Hantz S, Alain S, Denis F.

Gynecol Obstet Fertil. 2006 Jul-Aug;34(7-8):647-55. Epub 2006 Jun 27. Review. French.

PMID:
16807045
20.

Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.

Asiaf A, Ahmad ST, Mohammad SO, Zargar MA.

Eur J Cancer Prev. 2014 May;23(3):206-24. doi: 10.1097/CEJ.0b013e328364f273. Review.

PMID:
24129107
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk